Ilya Pharmas technology explained in a nice conversation in - Discovery Matters
Pod cast Discovery matters, episode 13. Scratched knees, smelly yogurt, and speedy wound healing
In press
Ilya Pharma interviewed by the real estate company Vasakronan, facilitating growth of companies in Uppsala Science Park
We advocate more pharmaceutical products to be tested in clinical trials to meet relevant efficacy endpoints and deliver clinical value in different wound segments.
Ilya Pharma interviewed in seminar of climate for growth companies in Uppsala County i
Mia Phillipson, Professor and co-founder of Ilya Pharma is sharing our growth story and future strategy at Uppsalaväxer in Almedalen-a political festival in Visby, Gotland.
Professor Mia Phillipson in prestigious scientific podcast describing the immune system and recent advances.
Professor Mia Phillipson, co-founder of Ilya Pharma is giving the view of our immune system, the scientific advances as well as opening up for using and targeting the immune system in development of next-generation biologics to treat current unmet medical needs. In Swedish. https://play.acast.com/s/alltduvelatveta/198omimmunforsvaretmedmiaphillipson
Ilya Pharmas CEO interviewed by the Naked Scientist for BBC Radio
Interview by Chris Smith, BBC Radio Cambridgeshire - Cutting-edge radio show that peers over the horizon at the science of tomorrow. Link : https://www.thenakedscientists.com/podcasts/naked-scientists-podcast/say-hello-tomorrows-tech 15:25 - Wound-healing bacteria The interview took place at the Hello Tomorrow Global Challenge event in Paris 15th of March where Ilya Pharma was selected Top 80 of companies in deep tech globally and also the winner of the wellbeing track, sponsored by Loreal.
Ilya Pharma QnA in Biopharma Reporter
Biopharma Reporter covers News & Analysis on Biopharmaceutical Manufacturing & Bioprocessing Tech.
Ilya Pharma in Microbiome Times
Microbiome Times is reporting in the ERA of the microbiome.
BioCentury Emerging Company Profile- WOUND-UP BACTERIA
Ilya Pharma and our innovative drug candidates was featured by BioCentury. We are very happy to be selected as an emerging company to keep track of!